Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 845 (ZNF845) is a novel transcription factor containing six tandem C2H2 zinc finger domains, first identified in cnidarians such as Hydra and Nematostella vectensis. It plays a crucial developmental role by promoting the differentiation of cnidocytes—the specialized stinging cells unique to cnidarians—while inhibiting the neural fate in embryonic development. ZNF845 functions as a key upstream regulator in the cnidocyte lineage, acting before expression of PaxA and other cnidocyte-specific transcription factors. It is one of several zinc finger proteins that arose in early animal evolution and does not have any direct orthologs or known regulatory functions in humans[1][2][3].
Biologically, ZNF845 acts upstream of PaxA and other markers in the cnidogenesis pathway, promotes cnidocyte (stinging cell) differentiation, and inhibits neural lineage, in part through regulation of nuclear receptor NR12
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 845 (ZNF845).